Evaluation of rivastigmine in Alzheimer's disease.

Neurodegenerative Disease Management
Kevin NguyenGeorge T Grossberg

Abstract

Dementia is the major cause of mortality and morbidity in older adults, with Alzheimer's disease (AD) being the most common cause. AD has a significant impact on economic and psychosocial status. Cholinesterase inhibitors (ChEIs) are currently the mainstay in the management of AD. Rivastigmine is the only ChEI that inhibits both acetylcholinesterase and butyrylcholinesterase enzymes in the brain. This dual inhibition makes it potentially more effective for AD patients. Its availability as both a transdermal formulation and oral capsule, may improve adherence rates and care giver satisfaction compared with other ChEIs. To date, the data from randomized clinical trials and post marketing observational studies have shown evidence for an impact on cognitive functions in AD with good safety and tolerability.

References

Jul 1, 1978·Neuropathology and Applied Neurobiology·E K PerryB E Tomlinson
Jan 1, 1995·Progress in Neuro-psychopharmacology & Biological Psychiatry·H NiigawaT Nishimura
Jun 11, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F ForetteG Gharabawi
Dec 10, 1999·Journal of Clinical Psychopharmacology·J S KennedyM H Ebert
Mar 29, 2002·International Journal of Geriatric Psychiatry·Roger Bullock, Claire Connolly
Dec 23, 2003·Current Medical Research and Opinion·Serge GauthierSteven G Potkin
Aug 9, 2005·The International Journal of Neuropsychopharmacology·Roger M LaneAlbert Enz
Jun 15, 2006·Alzheimer Disease and Associated Disorders·Agneta Nordberg
Jan 20, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·Matthias W RiepeFerenc Tracik
Apr 5, 2007·International Journal of Geriatric Psychiatry·Bengt WinbladRafael Blesa
Jul 31, 2007·Neurology·Jeffrey CummingsSilke Appel-Dingemanse
Jul 31, 2007·Neurology·Wolfgang OertelGeorg Adler
Nov 16, 2007·Current Medical Research and Opinion·François MercierSilke Appel-Dingemanse
Nov 30, 2007·Clinical Interventions in Aging·Maria Luisa OnorEugenio Aguglia
Apr 1, 2007·Neuropsychiatric Disease and Treatment·Thomas Müller
Apr 28, 2009·International Journal of Clinical Practice·A KurzG Lefèvre
Jan 15, 2010·CNS Neuroscience & Therapeutics·C SadowskyS Tekin
Nov 1, 2011·British Journal of Clinical Pharmacology·Salvatore SalomoneFilippo Drago
Nov 10, 2011·International Journal of Geriatric Psychiatry·Martin R FarlowMonique Somogyi
Sep 22, 2012·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Peter Pregelj
Apr 5, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Kongkiat KulkantrakornBandit Thinkhamrop

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00234637
NCT00305903
NCT00948766
NCT00506415
NCT00561392
NCT02703636
NCT00428389
NCT00000174

Software Mentioned

CIBIC
NOSGER
Plus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved